Skip to main navigation Skip to search Skip to main content

Maternal pre-pregnancy obesity, offspring cord blood DNA methylation, and offspring cardiometabolic health in early childhood: an epigenome-wide association study

  • Chantel L Martin (Creator)
  • Dereje D Jima (Creator)
  • Gemma C Sharp (Creator)
  • Lauren E McCullough (Creator)
  • Sarah S Park (Creator)
  • Kymberly M Gowdy (Creator)
  • David Skaar (Creator)
  • Michael Cowley (Creator)
  • Rachel L Maguire (Creator)
  • Bernard F Fuemmeler (Creator)
  • David N Collier (Creator)
  • Caroline L. Relton (Creator)
  • Susan K Murphy (Creator)
  • Cathrine Hoyo (Creator)

Dataset

Description

Pre-pregnancy obesity is an established risk factor for adverse sex-specific cardiometabolic health in offspring. Epigenetic alterations, such as in DNA methylation (DNAm), are a hypothesized link; however, sex-specific epigenomic targets remain unclear. Leveraging data from the Newborn Epigenetics Study (NEST) cohort, linear regression models were used to identify CpG sites in cord blood leukocytes associated with pre-pregnancy obesity in 187 mother-female and 173 mother-male offsprings. DNAm in cord blood was measured using the Illumina HumanMethylation450k BeadChip. Replication analysis was conducted among the Avon Longitudinal Study of Parents and Children (ALSPAC) cohort. Associations between pre-pregnancy obesity-associated CpG sites and offspring BMI z-score (BMIz) and blood pressure (BP) percentiles at 4–5-years of age were also examined. Maternal pre-pregnacy obesity was associated with 876 CpGs in female and 293 CpGs in male offspring (false discovery rate
Date made available2023
PublisherTaylor & Francis

Cite this